Intravenous Ketamine: Clinical Trials

11 trials of Intravenous Ketamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 5 Phase 4, 4 Phase 1, 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 45Terminated 2, Active not recruiting 1, Completed 1, Unknown 1
Phase 14Completed 3, Withdrawn 1
Phase 24Completed 3, Withdrawn 1
Phase 31Suspended 1

Follow Intravenous Ketamine: new trials by email Literature Review of Intravenous Ketamine trials Research Report on Intravenous Ketamine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation
Ketamine (Ketalar) - Chronic Pain, Ketamine
Not yet recruitingStanford University8002026-10-012026-09-15
Repeated Neurocognitive Measurements in Depressed Patients
Intravenous Ketamine - Depression, Unipolar
Phase 1 / Phase 2WithdrawnJay Fournier2025-05-012026-02-25
IV and Intrathecal Ketamine in Cesarean Section
Intrathecal ketamine, Intravenous ketamine - Cesarean Section, Analgesia
Phase 4CompletedAssiut University602023-02-012025-03-06
Ketamine + Mindfulness for Depression
Intravenous Ketamine, Brief Mindfulness Exercises, Academic Exercises - Depression, Unipolar
Phase 1 / Phase 2CompletedRebecca Price432022-02-012024-08-20
Repeated Neurocognitive Measurements in Depressed Patients
Intravenous Ketamine - Depression, Unipolar
Phase 1 / Phase 2CompletedRebecca Price152021-09-162024-08-20
Ketamine + Cognitive Training for Suicidality in the Medical Setting
Intravenous ketamine, Cognitive training, Sham Training - Suicide, Attempted
Phase 4Active not recruitingRebecca Price2002021-03-152026-03-24
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
Intravenous ketamine, Cognitive training, Sham Training - Suicide, Attempted
Phase 4TerminatedRebecca Price162019-12-192024-07-22
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
Intravenous Ketamine, Intranasal Ketamine - Trauma, Fractures, Closed
Phase 4TerminatedUniversity of Alabama at Birmingham402019-09-092023-04-20
Ketamine Versus Electroconvulsive Therapy in Depression
Intravenous Ketamine, Electroconvulsive Therapy - Depressive Disorder, Major, Bipolar Depression
Phase 3SuspendedUniversity of Ottawa2402018-10-292023-09-01
Intravenous Ketamine Plus Neurocognitive Training for Depression
Intravenous ketamine, Computer-based Cognitive Training - Depression
Phase 1 / Phase 2CompletedRebecca Price1542017-12-012024-03-19
Ketamine v. Ketorolac for Management of Generalized Tension Type Headache
Intravenous ketamine, Ketorolac, Normal saline - Migraine
Phase 4UnknownThe Brooklyn Hospital Center602016-02-012018-07-06

Conditions studied

Depressive Disorder (3)  ·  Agnosia (2)  ·  Depression (2)  ·  Suicide, Attempted (2)  ·  Bipolar Disorder (1)  ·  Chronic Pain (1)  ·  Depressive Disorder, Major (1)  ·  Emergencies (1)  ·  Fractures, Bone (1)  ·  Fractures, Closed (1)  ·  Mental Disorders (1)  ·  Migraine Disorders (1)  ·  Mood Disorders (1)  ·  Wounds and Injuries (1)

Sponsors

Rebecca Price (5)  ·  Assiut University (1)  ·  Jay Fournier (1)  ·  Stanford University (1)  ·  The Brooklyn Hospital Center (1)  ·  University of Alabama at Birmingham (1)  ·  University of Ottawa (1)

Countries

United States (9)  ·  Canada (1)  ·  Egypt (1)

Top investigators

James Statler, MD (1)  ·  Judson Barber, MD (1)  ·  Pierre Blier, MD, PhD (1)  ·  Rebecca B Price, PhD (1)  ·  Rebecca Price, PhD (1)

Results publications

PMID 32487236, PMID 33271040, PMID 37155171, PMID 39311825, PMID 40964432

NIH funding

R01MH113857 (1), R01MH124983 (1)